ATE413453T1 - Raf/ras-bindende verbindungen - Google Patents

Raf/ras-bindende verbindungen

Info

Publication number
ATE413453T1
ATE413453T1 AT02793099T AT02793099T ATE413453T1 AT E413453 T1 ATE413453 T1 AT E413453T1 AT 02793099 T AT02793099 T AT 02793099T AT 02793099 T AT02793099 T AT 02793099T AT E413453 T1 ATE413453 T1 AT E413453T1
Authority
AT
Austria
Prior art keywords
raf
ras
binding compounds
ras binding
compounds
Prior art date
Application number
AT02793099T
Other languages
English (en)
Inventor
Carlo Riccardi
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE413453T1 publication Critical patent/ATE413453T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • External Artificial Organs (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02793099T 2001-12-21 2002-12-20 Raf/ras-bindende verbindungen ATE413453T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01000788 2001-12-21

Publications (1)

Publication Number Publication Date
ATE413453T1 true ATE413453T1 (de) 2008-11-15

Family

ID=8176119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793099T ATE413453T1 (de) 2001-12-21 2002-12-20 Raf/ras-bindende verbindungen

Country Status (9)

Country Link
US (1) US20050164906A1 (de)
EP (1) EP1465996B1 (de)
JP (1) JP2005525092A (de)
AT (1) ATE413453T1 (de)
AU (1) AU2002358780B2 (de)
CA (1) CA2469263A1 (de)
DE (1) DE60229781D1 (de)
IL (1) IL162601A0 (de)
WO (1) WO2003054193A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740854B2 (en) * 2001-05-02 2010-06-22 Purdue Research Foundation Treatment of macrophage mediated disease
EP1622646B1 (de) * 2003-05-06 2012-08-08 Purdue Research Foundation Behandlung von Lupus mit den Makrophagen oder dem Folat-Rezeptor als Target
FR2875136B1 (fr) * 2004-09-10 2007-12-14 Assist Publ Hopitaux De Paris Utilisation de la proteine gilz exprimee dans les cellules dendritiques pour moduler la reponse immune specifique d'un antigene
EP1904183B1 (de) 2005-07-05 2014-10-15 Purdue Research Foundation Pharmazeutische Zusammensetzung zur Behandlung von Arthrose
WO2014172639A1 (en) * 2013-04-19 2014-10-23 Ruga Corporation Raf kinase inhibitors
EP3740198A4 (de) * 2018-01-18 2023-08-09 Fred Hutchinson Cancer Center Veränderung von entzündungszuständen von immunzellen in vivo durch modulation von zellaktivierungszuständen
US11524091B2 (en) * 2018-08-21 2022-12-13 Augusta University Research Institute, Inc. GILZ formulations for wound healing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0884385A1 (de) * 1997-04-28 1998-12-16 Applied Research Systems Ars Holding N.V. Intrazelluläre Modulatoren für apoptopischen Zelltotwegen
US6867283B2 (en) * 2001-05-16 2005-03-15 Technion Research & Development Foundation Ltd. Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells

Also Published As

Publication number Publication date
EP1465996A2 (de) 2004-10-13
WO2003054193A3 (en) 2003-10-23
AU2002358780B2 (en) 2008-03-06
WO2003054193A2 (en) 2003-07-03
CA2469263A1 (en) 2003-07-03
IL162601A0 (en) 2005-11-20
US20050164906A1 (en) 2005-07-28
DE60229781D1 (de) 2008-12-18
JP2005525092A (ja) 2005-08-25
EP1465996B1 (de) 2008-11-05
AU2002358780A1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
NO950319L (no) Inhibitorer for c-AMP fosfodiesterase og TNF
ID27535A (id) Turunan pirasola sebagai inhibitor p-38 map kinase
ATE267200T1 (de) Bicyclische kinase inhibitoren
SE0101675D0 (sv) Novel composition
MXPA05011296A (es) Conjugados de fosfonato inhibidores de la cinasa.
SE0301373D0 (sv) Novel compounds
MXPA02011320A (es) Derivados de pirazol triciclico como inhibidores de cinasa.
ATE554087T1 (de) Neue kinaseinhibitoren
DE602004006618D1 (de) Azaindolverbindungen als kinaseinhibitoren
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
DK1648905T3 (da) Inhibitorer for thienopyridin- og furopyridinkinase
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
NO20044221L (no) Nye forbindelser
BR0113931A (pt) Compostos heterocìclicos ligantes receptores de quimiocinas
IS2376B (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
MXPA05013076A (es) Compuestos de isoindolina-1-ona como inhibidores de cinasa.
NO20055791L (no) Pyridinylacetonitriler
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
MXPA05009151A (es) Inhibidores de cinasa heterociclica.
ATE413453T1 (de) Raf/ras-bindende verbindungen
BRPI0712064B8 (pt) derivados de (2r)-2-fenilpropanamida, uso e processo para preparação dos mesmos e composições farmacêuticas
DK0975588T3 (da) Antipicornavirale forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
DE502004009136D1 (de) NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb
EA200701881A1 (ru) 1,3-тиазол-5-карбоксамиды, используемые в качестве противораковых химиотерапевтических агентов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties